What are the recommendations regarding frequency of monitoring while on COUMADIN® (Warfarin Sodium Tablets, USP)?
Regular monitoring of INR should be performed on all treated patients.1 Those at high risk of bleeding may benefit from more frequent INR monitoring, careful dose adjustment to desired INR, and a shorter duration of therapy.1 Patients should be instructed about prevention measures to minimize risk of bleeding and to report immediately to physicians signs and symptoms of bleeding (see PRECAUTIONS: Information for Patients).1 REFERENCE
Related Questions
- What are the recommendations regarding frequency of monitoring while on COUMADIN® (Warfarin Sodium Tablets, USP)?
- What are the current recommended therapeutic ranges for COUMADIN® (Warfarin Sodium Tablets, USP) therapy?
- What are some drug interaction considerations when taking COUMADIN® (Warfarin Sodium Tablets, USP)?